Hydrelle

Product Details

FDA Approval Date

Approved as Elevess in 2007. The product was re-launched in July 2009 with the name, Hydrelle
Hydrelle contains lidocaine which is an anesthetic.

Approved Use

For injection into the mid to deep dermis for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds)

Off Label Use

Smoothing facial creases of the forehead and brow, plumping the eyebrows or temporal region, smoothing under eye hollows, enhancing volume and defining contours of the cheeks, chin and jawline, softening the appearance of scars and other depressed defects

Duration

6 months or more

Side Effects

Bruising, swelling, redness

Adverse Outcomes

May be visible or felt if injected superficially. In very rare cases may develop nodules (small bumps beneath the skin)

Return to full product listing.